Herbl’s high hopes run out of green
For the majority of the past five years, Goleta-based Herbl was shipping a lot of cannabis and making a lot of green in the process, reporting that sales exceeded $200 million in 2022. But as of August 2023, the company has largely ceased operations and filed for receivership. Once the largest cannabis distributor in the Read More →
Olaplex fails to meet expectations again, lowers guidance
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen gives confidence to investors on pending purchase
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Eloise Cohen, a major arts supporter in Thousand Oaks, dies at 73
There are just a few people in any community who can light up a room, raise money for any cause and elevate arts and culture with grace and style. Eloise Cohen was one of them. She and her husband Chuck, an attorney and former Thousand Oaks mayor, were the Conejo Valley first couple for many Read More →
MannKind excites investors, analysts after huge bump in sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen delivers earnings beat despite acquisition headaches
Amgen delivered a sound beat of Wall Street analysts’ predictions for its second quarter of 2023 en route to posting a record revenue. The biotech giant reported a total revenue of just under $7 billion, beating the Yahoo Finance estimate by 4.6% and causing the stock to jump up 2.3% in after-hours trading. Amgen attributed Read More →
Our view: Vandenberg loses bid for STARCOM designation but keeps Space Force focus
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
